PGRMC1 and head and neck cancer: In this present study, we assessed the prognostic impact of aberrant PGRMC1 expression in head and neck cancer and other cancers to identify patients who may benefit from anti-cancer therapy targeting PGRMC1 and also investigated the oncogenic mechanism of PGRMC1 over-expression in cancer cells.